Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Mirum Pharmaceuticals $200 million private placement
We advised the placement agents on the transaction
Amazon.com $15 billion notes offering
We advised the underwriters on the offering
GRAIL $300 million at-the-market offering
We advised the sales agents on the offering
Flex $750 million notes offering
We advised the underwriters on the offering
Bloom Energy $2.5 billion convertible senior notes offering
The 0% convertible senior notes are due 2030
GRAIL $325 million private placement
The PIPE included common stock and pre-funded warrants
Oruka Therapeutics $200 million at-the-market offering
We advised Oruka on the offering
ADTRAN Holdings $201.25 million convertible senior notes offering
The 3.75% convertible senior notes are due 2030
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants